First Header Logo Second Header Logo

Connection

Kathleen Hayden to Cognition Disorders

This is a "connection" page, showing publications Kathleen Hayden has written about Cognition Disorders.
Connection Strength

3.844
  1. Hayden KM, Gaussoin SA, Hunter JC, Manson JE, Sachs BC, Shadyab AH, Tindle HA, Mossavar-Rahmani Y, Mozhui K, Snively BM, Rapp SR, Resnick SM. Cognitive resilience among APOE e4 carriers in the oldest old. Int J Geriatr Psychiatry. 2019 12; 34(12):1833-1844.
    View in: PubMed
    Score: 0.554
  2. Hayden KM, Lutz MW, Kuchibhatla M, Germain C, Plassman BL. Effect of APOE and CD33 on Cognitive Decline. PLoS One. 2015; 10(6):e0130419.
    View in: PubMed
    Score: 0.415
  3. Hayden KM, Makeeva OA, Newby LK, Plassman BL, Markova VV, Dunham A, Romero HR, Melikyan ZA, Germain CM, Welsh-Bohmer KA, Roses AD. A comparison of neuropsychological performance between US and Russia: preparing for a global clinical trial. Alzheimers Dement. 2014 Nov; 10(6):760-768.e1.
    View in: PubMed
    Score: 0.390
  4. Hayden KM, Potter GG. More evidence for the benefits of cognitive activity over the lifespan. Evid Based Med. 2014 Jun; 19(3):114.
    View in: PubMed
    Score: 0.376
  5. Hayden KM, McEvoy JM, Linnertz C, Attix D, Kuchibhatla M, Saunders AM, Lutz MW, Welsh-Bohmer KA, Roses AD, Chiba-Falek O. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging. Alzheimers Dement. 2012 Sep; 8(5):381-8.
    View in: PubMed
    Score: 0.340
  6. Hayden KM, Welsh-Bohmer KA. Epidemiology of cognitive aging and Alzheimer's disease: contributions of the cache county utah study of memory, health and aging. Curr Top Behav Neurosci. 2012; 10:3-31.
    View in: PubMed
    Score: 0.327
  7. Hayden KM, Reed BR, Manly JJ, Tommet D, Pietrzak RH, Chelune GJ, Yang FM, Revell AJ, Bennett DA, Jones RN. Cognitive decline in the elderly: an analysis of population heterogeneity. Age Ageing. 2011 Nov; 40(6):684-9.
    View in: PubMed
    Score: 0.319
  8. Hayden KM, Zandi PP, West NA, Tschanz JT, Norton MC, Corcoran C, Breitner JC, Welsh-Bohmer KA. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study. Arch Neurol. 2009 Nov; 66(11):1378-83.
    View in: PubMed
    Score: 0.281
  9. Hayden KM, Zandi PP, Khachaturian AS, Szekely CA, Fotuhi M, Norton MC, Tschanz JT, Pieper CF, Corcoran C, Lyketsos CG, Breitner JC, Welsh-Bohmer KA. Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology. 2007 Jul 17; 69(3):275-82.
    View in: PubMed
    Score: 0.240
  10. Carmichael OT, Neiberg RH, Dutton GR, Hayden KM, Horton E, Pi-Sunyer FX, Johnson KC, Rapp SR, Spira AP, Espeland MA. Long-term Change in Physiological Markers and Cognitive Performance in Type 2 Diabetes: The Look AHEAD Study. J Clin Endocrinol Metab. 2020 12 01; 105(12).
    View in: PubMed
    Score: 0.151
  11. Ong KL, Morris MJ, McClelland RL, Hughes TM, Maniam J, Fitzpatrick AL, Martin SS, Luchsinger JA, Rapp SR, Hayden KM, Sandfort V, Allison MA, Rye KA. Relationship of Lipids and Lipid-Lowering Medications With Cognitive Function: The Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2018 04 01; 187(4):767-776.
    View in: PubMed
    Score: 0.126
  12. Peters ME, Rosenberg PB, Steinberg M, Norton MC, Welsh-Bohmer KA, Hayden KM, Breitner J, Tschanz JT, Lyketsos CG. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. Am J Geriatr Psychiatry. 2013 Nov; 21(11):1116-24.
    View in: PubMed
    Score: 0.088
  13. Peters ME, Rosenberg PB, Steinberg M, Tschanz JT, Norton MC, Welsh-Bohmer KA, Hayden KM, Breitner JC, Lyketsos CG. Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study. Am J Geriatr Psychiatry. 2012 May; 20(5):416-24.
    View in: PubMed
    Score: 0.084
  14. Mayeux R, Reitz C, Brickman AM, Haan MN, Manly JJ, Glymour MM, Weiss CC, Yaffe K, Middleton L, Hendrie HC, Warren LH, Hayden KM, Welsh-Bohmer KA, Breitner JC, Morris JC. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. Alzheimers Dement. 2011 Jan; 7(1):15-34.
    View in: PubMed
    Score: 0.076
  15. Wengreen HJ, Munger RG, Corcoran CD, Zandi P, Hayden KM, Fotuhi M, Skoog I, Norton MC, Tschanz J, Breitner JC, Welsh-Bohmer KA. Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. J Nutr Health Aging. 2007 May-Jun; 11(3):230-7.
    View in: PubMed
    Score: 0.059
  16. Hulette CM, Ervin JF, Edmonds Y, Antoine S, Stewart N, Szymanski MH, Hayden KM, Pieper CF, Burke JR, Welsh-Bohmer KA. Cerebrovascular smooth muscle actin is increased in nondemented subjects with frequent senile plaques at autopsy: implications for the pathogenesis of Alzheimer disease. J Neuropathol Exp Neurol. 2009 Apr; 68(4):417-24.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.